Traws Pharma grants stock options to director
Traws Pharma, Inc. director Clarke Trafford received a grant of stock options to purchase 14,150 shares of common stock at an exercise price of $0.68 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Traws Pharma, Inc. director Clarke Trafford received a grant of stock options to purchase 14,150 shares of common stock at an exercise price of $0.68 per share. The options were awarded under the company’s 2021 Incentive Compensation Plan, vest 100% one year after the grant date, and expire on July 9, 2036, leaving Trafford with 14,150 options following the award.
Insider Trade Summary
Grant/Award: 14,150 shares
Grant/Award
1 txn
Insider
Clarke Trafford
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 14,150 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 14,150 contracts (Direct)
Holdings Before and After:
Stock Option (right to buy), 0 to 14,150 contracts (Direct)
Footnotes (1)
- F1. Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.
Key Figures
Stock options granted: 14,150 options
Exercise price: $0.68 per share
Underlying shares: 14,150 shares
+3 more
6 metrics
Stock options granted
14,150 options
Grant of stock options to director Clarke Trafford on 2026-07-09
Exercise price
$0.68 per share
Exercise price of the granted stock options
Underlying shares
14,150 shares
Each option is exercisable for one share of common stock
Total options after grant
14,150 options
Total derivative securities held following this award
Exercise date
2027-07-09
Date from which the options are first exercisable after full vesting
Expiration date
2036-07-09
Final expiration date of the stock option award
Key Terms
Stock Option (right to buy), 2021 Incentive Compensation Plan, exercise price, expiration date
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
2021 Incentive Compensation Plan financial
"awarded by the Issuer's compensation committee under the Issuer's 2021 Incentive Compensation Plan"
exercise price financial
"conversion_or_exercise_price: 0.6800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-07-09"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is the insider involved in this TRAW Form 4 transaction?
The insider is Clarke Trafford, a director of Traws Pharma, Inc. He reported receiving a grant of stock options as equity compensation from the company’s board compensation committee under the 2021 Incentive Compensation Plan.
What type of security did Clarke Trafford receive in the TRAW filing?
Clarke Trafford received a stock option (right to buy) award. Each option is exercisable for one share of Traws Pharma common stock, providing equity-based compensation rather than an immediate stock purchase in the open market.
How many stock options were granted to Clarke Trafford in TRAW?
Clarke Trafford was granted 14,150 stock options. Following this grant, his reported holdings of this option award total 14,150 derivative securities, all tied to an equivalent number of underlying shares of Traws Pharma common stock.
What is the exercise price of Clarke Trafford’s TRAW stock options?
The stock options carry an exercise price of $0.68 per share. This means Trafford can purchase Traws Pharma common stock at $0.68 per share upon exercise, subject to vesting and before the options’ expiration date.
When do Clarke Trafford’s TRAW stock options vest and expire?
The options vest 100% on the first anniversary of the July 9, 2026 grant date. They have an expiration date of July 9, 2036, giving a long window for potential exercise once fully vested.
Under which plan were the TRAW stock options to Clarke Trafford granted?
The options were granted under Traws Pharma’s 2021 Incentive Compensation Plan, as amended and/or restated. The award was approved by the company’s compensation committee, which is comprised of independent directors overseeing equity compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
